Curos Port Protector – Disinfection Cap
The Curos® Port Protector is a simple, innovative, disposable infection prevention product intended for use on swabbable luer access valves as a disinfecting cleaner prior to line access and to act as a physical barrier to contamination between line accesses. Curos will disinfect the valve three minutes after application and act as a physical barrier to contamination for up to 7 days if not removed.
The Curos® Port Protector:
- The effectiveness of Curos were tested in vitro against Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli and Pseudomonas aeruginosa, Candida glabrata, Candida albicans.1
- Assures high visibility compliance with hospital infection prevention protocols – the vibrant green cap is easy to see and will not be confused with other color-indicated therapies
- Protects iv access ports and needleless connectors between accesses – keeping ports always protected and clean
- Minimizes packaging waste
Simply peel off the seal and twist Curos® Port Protector disinfection cap over the top of a luer-activated IV access port. Inside this revolutionary green cap is a 70% IPA (isopropyl alcohol) saturated sponge-like foam. Once secured, the Curos Port Protector automatically provides effective, consistent and reliable passive disinfection of the port.
Hospitalized patients with bloodstream infections have extended lengths of stay, which increase patient and hospital costs, and contribute to higher incidence of mortality.3-7
Valves have been associated with increases in BSI rates.2 As part of a broader infection prevention program, effective disinfection of valves may reduce microbial ingress into the patient’s bloodstream which may lead to improvements in catheter-related bloodstream infection (CRBSI) rates.
1.For more information refer to Wenzel et al. The Impact of Hospital-Acquired Bloodstream Infections Emerging Infectious Disease • 2001 Vol 7, No 2. 174-177
2.Jarvis WR, Murphy C, Hall KK, Fogle PJ, Karchmer TB, Harrington G, Salgado C, Giannetta ET, Cameron C, Sherertz RJ. Health care-associated bloodstream infections associated with negative- or positive-pressure or displacement mechanical valve needleless connectors. Clin Infect Dis. 2009 Dec 15;49(12):1821-7. Free Article
3.Pittet, D., Tarara, D., Wenzel, R. P. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs and attributable mortalilty. JAMA 1994; 271:1598-601.
4.Eggimann, P., Sax, H., Pittet, D. Catheter-related infections. Microbes Infect 2004; 6:1033-42.
5.Byers, K. E., Adal, K. A., Anglim, A. M., Farr, B. M. Case fatality rate for catheter-related bloodstream infections: a meta-analysis (abstract 43). 5th Annual Meeting of the Society of Healthcare Epidemiology of America. San Diego: Mt. Royal, NJ: The Society of Healthcare Epidemiology of America; 1995; 16(4):23.
6.Rosenthal, V. D., Guzman, S., Migone, O., Crnich, C. J. The attributable cost, length of hospital stay, and mortality of central line-associated bloodstream infection in intensive care departments in Argentina: a prospective, matched analysis. Am J Infect Control 2003; 31:475-80.